Ligand Pharmaceuticals | LGND - Marktkapitalisierung

Aktienkurs
231.27
Täglich Wechseln
2.79 1.22%
Monatlich
13.06%
Jährlich
114.00%
Q2 Prognose
226.72




Marktkapitalisierung Veränderung Datum
Agenus USD 107M 16M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Enviri Corporation USD 1.45B 423M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
Merck USD 261.26B 51.62B 2025-12
Pacira USD 1.06B 94M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Veracyte USD 3.33B 627M 2025-12